These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9399239)

  • 1. Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection.
    LeWitt PA; Trosch RM
    Mov Disord; 1997 Nov; 12(6):1064-7. PubMed ID: 9399239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effects on heart-rate variability and cardiovascular reflex tests after botulinum toxin treatment of cervical dystonia.
    Nebe A; Schelosky L; Wissel J; Ebersbach G; Scholz U; Poewe W
    Mov Disord; 1996 May; 11(3):337-9. PubMed ID: 8723158
    [No Abstract]   [Full Text] [Related]  

  • 3. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
    Comella CL; Shannon KM; Jaglin J
    Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of dystonia of the lateral pterygoid muscle with botulinum toxin A.
    Mendes RA; Upton LG
    Br J Oral Maxillofac Surg; 2009 Sep; 47(6):481-3. PubMed ID: 18829144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuralgic amyotrophy following botulinum toxin injection.
    Alcalay RN; Simões RM; Feigin A; Frucht S
    Parkinsonism Relat Disord; 2010 May; 16(4):301-2. PubMed ID: 19815448
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulism-like syndrome after injections of botulinum toxin.
    Cobb DB; Watson WA; Fernandez MC
    Vet Hum Toxicol; 2000 Jun; 42(3):163. PubMed ID: 10839321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
    Brin MF; Comella CL; Jankovic J; Lai F; Naumann M;
    Mov Disord; 2008 Jul; 23(10):1353-60. PubMed ID: 18546321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides.
    Bulstrode NW; Grobbelaar AO
    Aesthetic Plast Surg; 2002; 26(5):356-9. PubMed ID: 12432474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysphagia as a side effect of botulinum toxin injection.
    Kwek AB; Tan EK; Luman W
    Med J Malaysia; 2004 Oct; 59(4):544-6. PubMed ID: 15779592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aspects of the complexity of cervical dystonia].
    Hefter H
    Nervenarzt; 2008 Jun; 79 Suppl 1():15-8. PubMed ID: 18927959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report of acute polyradiculoneuritis developing after multiple injections of botulinum toxin for cervical dystonia].
    Onoue H; Matsunobu A; Nagaishi A; Yukitake M; Kuroda Y
    Rinsho Shinkeigaku; 2004 Jan; 44(1):20-4. PubMed ID: 15199733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of spasmotic torticollis with botulinum toxin A. A 5-year experience].
    Borgmann R
    Tidsskr Nor Laegeforen; 1997 May; 117(13):1889-91. PubMed ID: 9214007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
    Factor SA; Molho ES; Evans S; Feustel PJ
    Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe botulinum toxin type A injection in patients with history of eyelid ptosis.
    Ghalamkarpour F; Aghazadeh Y; Odabaei G
    J Cosmet Dermatol; 2009 Jun; 8(2):98-102. PubMed ID: 19527332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromuscular blockade with botulinum toxin. From toxin to therapeutic agent].
    Einecke D
    MMW Fortschr Med; 2001 May; 143 Suppl 2():95-6. PubMed ID: 11434276
    [No Abstract]   [Full Text] [Related]  

  • 17. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraindications and complications with the use of botulinum toxin.
    Klein AW
    Clin Dermatol; 2004; 22(1):66-75. PubMed ID: 15158548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ptosis as a complication of botulinum toxin injection.
    Omoigui S; Irene S
    Pain Med; 2005; 6(2):149-51. PubMed ID: 15773880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.